• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性离子包覆的超小 MnO 纳米颗粒实现高灵敏的加权对比增强脑成像。

Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive -Weighted Contrast-Enhanced Brain Imaging.

机构信息

State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, and The Key Laboratory for Chemical Biology of Fujian Province, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.

Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.

出版信息

ACS Appl Mater Interfaces. 2022 Jan 26;14(3):3784-3791. doi: 10.1021/acsami.1c20617. Epub 2022 Jan 12.

DOI:10.1021/acsami.1c20617
PMID:35019261
Abstract

Manganese oxide nanoparticles (NPs) have attracted increasing attention recently as contrast agents (CAs) for magnetic resonance imaging (MRI). However, the clinical translation and popularization of conventional MnO NPs are hampered by their relatively poor imaging performance. Herein, we report the construction of ultrasmall MnO NPs (USMnO) a one-pot synthetic approach that show a much better capability of -weighted contrast enhancement for MRI ( = 15.6 ± 0.4 mM s at 0.5 T) than MnCl and conventional large-sized MnO NPs (MnO-22). These USMnO are further coated with zwitterionic dopamine sulfonate (ZDS) molecules, which improves their biocompatibility and prevents nonspecific binding of serum albumins. Interestingly, USMnO@ZDS are capable of passing through the blood-brain barrier (BBB), which enables the acquisition of clear images showing brain anatomic structures with -weighted contrast-enhanced MRI. Therefore, our USMnO@ZDS could be used as a promising MRI CA for the flexible and accurate diagnosis of brain diseases, which is also instructive for the construction of manganese-based CA with a high MRI performance.

摘要

近年来,氧化锰纳米粒子(NPs)作为磁共振成像(MRI)的对比剂(CAs)引起了越来越多的关注。然而,由于其成像性能相对较差,传统 MnO NPs 的临床转化和推广受到了阻碍。在此,我们报告了超小 MnO NPs(USMnO)的构建-一种一锅合成方法,其用于 MRI 的 T1 加权对比增强能力明显优于 MnCl2 和传统的大尺寸 MnO NPs(MnO-22)(=15.6±0.4mM s,在 0.5 T 下)。这些 USMnO 进一步被带负电荷的多巴胺磺酸盐(ZDS)分子包覆,提高了其生物相容性并防止了血清白蛋白的非特异性结合。有趣的是,USMnO@ZDS 能够穿透血脑屏障(BBB),从而可以获得清晰的图像,显示 T1 加权对比增强 MRI 的脑解剖结构。因此,我们的 USMnO@ZDS 可用作一种有前途的 MRI CA,用于灵活、准确地诊断脑部疾病,这也为构建具有高 MRI 性能的基于锰的 CA 提供了启示。

相似文献

1
Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive -Weighted Contrast-Enhanced Brain Imaging.两性离子包覆的超小 MnO 纳米颗粒实现高灵敏的加权对比增强脑成像。
ACS Appl Mater Interfaces. 2022 Jan 26;14(3):3784-3791. doi: 10.1021/acsami.1c20617. Epub 2022 Jan 12.
2
One-pot preparation of hydrophilic manganese oxide nanoparticles as T nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo.一锅法制备亲水性氧化锰纳米粒子作为 T1 纳米对比剂用于肾癌的体外和体内分子磁共振成像。
Biosens Bioelectron. 2018 Apr 15;102:1-8. doi: 10.1016/j.bios.2017.10.047. Epub 2017 Oct 27.
3
Improving the sensitivity of contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons.提高对比度增强 MRI 的灵敏度和使用 MnO 八面体进行超低剂量敏感诊断肿瘤。
Theranostics. 2021 May 8;11(14):6966-6982. doi: 10.7150/thno.59096. eCollection 2021.
4
Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.介孔硅锰酸镁包覆的纳米颗粒作为多刺激响应 T1-MRI 对比剂和药物载体。
Acta Biomater. 2016 Jan;30:378-387. doi: 10.1016/j.actbio.2015.11.036. Epub 2015 Nov 18.
5
Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.基于超小 MnO 纳米粒子的肿瘤靶向正 MRI 造影剂的制备与评价。
Colloids Surf B Biointerfaces. 2015 Jul 1;131:148-54. doi: 10.1016/j.colsurfb.2015.04.047. Epub 2015 Apr 29.
6
Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T/T Dual-Contrast Magnetic Resonance Imaging.聚乙二醇(PEG)包覆的超小粒径、高弛豫率锰掺杂氧化铁纳米粒子的合成及其在 T/T 双模态磁共振成像中的应用。
Int J Nanomedicine. 2019 Oct 24;14:8499-8507. doi: 10.2147/IJN.S219749. eCollection 2019.
7
Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.叶酸偶联 MnO 纳米粒子作为 T1 对比剂用于微小脑胶质瘤的磁共振成像。
ACS Appl Mater Interfaces. 2014 Nov 26;6(22):19850-7. doi: 10.1021/am505223t. Epub 2014 Nov 4.
8
Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.用于分子 T1 MR 成像的水溶性 MnO 纳米胶体:一种简便的一锅合成法、体内 T1 MR 成像及弛豫率分析。
ACS Appl Mater Interfaces. 2010 Oct;2(10):2949-55. doi: 10.1021/am100641z.
9
In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.体内双模式荧光和磁共振成像引导的具有良好生物相容性的氧化锰纳米粒子的淋巴结成像。
Molecules. 2017 Dec 12;22(12):2208. doi: 10.3390/molecules22122208.
10
Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.双功能吡咯烷-2-酮封端的锰氧化物纳米粒子用于磁共振和荧光成像的联合。
ACS Appl Mater Interfaces. 2019 Apr 10;11(14):13069-13078. doi: 10.1021/acsami.8b21762. Epub 2019 Mar 27.

引用本文的文献

1
The role of manganese-based MRI contrast agents for cancer theranostics: Where do we stand in 2025?锰基磁共振成像造影剂在癌症诊疗中的作用:到2025年我们处于什么水平?
Theranostics. 2025 Mar 15;15(9):4147-4174. doi: 10.7150/thno.108705. eCollection 2025.
2
Efficient and Specific PDGFRβ-Targeting Dual-Mode T-T MRI Nanoprobe for Early Diagnosis of Non-Alcoholic Fatty Liver.用于非酒精性脂肪肝早期诊断的高效特异性靶向血小板衍生生长因子受体β的双模态T-T磁共振成像纳米探针
Adv Sci (Weinh). 2025 Jun;12(23):e2413788. doi: 10.1002/advs.202413788. Epub 2025 Mar 7.
3
Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics.
用于基于磁共振成像的多模态成像与诊疗的氧化锰纳米颗粒
Molecules. 2024 Nov 26;29(23):5591. doi: 10.3390/molecules29235591.
4
Rational Design of Magnetic Nanoparticles as T-T Dual-Mode MRI Contrast Agents.作为 T1/T2 双模式 MRI 对比剂的磁性纳米粒子的合理设计。
Molecules. 2024 Mar 18;29(6):1352. doi: 10.3390/molecules29061352.
5
Magnetic Nanoparticle-Based High-Performance Positive and Negative Magnetic Resonance Imaging Contrast Agents.基于磁性纳米颗粒的高性能正负磁共振成像造影剂
Pharmaceutics. 2023 Jun 15;15(6):1745. doi: 10.3390/pharmaceutics15061745.
6
Acid-triggered aggregation of Janus nanoparticles for enhanced imaging-guided photothermal therapy.用于增强成像引导光热治疗的酸触发Janus纳米颗粒聚集
Nanoscale Adv. 2022 Nov 22;5(1):268-276. doi: 10.1039/d2na00622g. eCollection 2022 Dec 20.
7
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations.生物成像引导的纳米药物临床转化的药物评价。
J Nanobiotechnology. 2022 May 19;20(1):236. doi: 10.1186/s12951-022-01451-4.